Infrastructure Capital Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Infrastructure Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $347,862 - $412,661	-606 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $44,916 - $53,061	95 Added 18.59%	606 $338,000
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $4,914 - $6,030	11 Added 2.2%	511 $242,000
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $40,177 - $51,070	84 Added 20.19%	500 $242,000
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $2.22 Million - $2.69 Million	-4,084 Reduced 90.76%	416 $233,000

Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $2.22 Million - $2.9 Million	4,500 New	4,500 $2.81 Million

1,426

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Infrastructure Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Infrastructure Capital Advisors, LLC with notifications on news.